Wegener's Granulomatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials
• Forums

A Study Evaluating the Safety and Efficacy of Ristova (Rituximab) in Combination With Glucocorticoids in Patients With Wegener's Granulomatosis or Microscopic Polyangitis
Condition:   Wegener's Granulomatosis, Microscopic PolyangiitisInterventions:   Drug: methylprednisolone;   Drug: prednisone;   Drug: rituximab [Ristova]Sponsor:   Hoffmann-La RocheNot yet recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2014 Category: Research Source Type: clinical trials

A Study Evaluating the Safety and Efficacy of Ristova (Rituximab) in Combination With Glucocorticoids in Patients With Wegener's Granulomatosis or Microscopic Polyangitis
Condition:   Wegener's Granulomatosis, Microscopic PolyangiitisInterventions:   Drug: methylprednisolone;   Drug: prednisone;   Drug: rituximab [Ristova]Sponsor:   Hoffmann-La RocheNot yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2014 Category: Research Source Type: clinical trials

A Study Evaluating the Safety and Efficacy of Ristova (Rituximab) in Combination With Glucocorticoids in Patients With Wegener's Granulomatosis or Microscopic Polyangitis
Condition:   Wegener's Granulomatosis, Microscopic PolyangiitisInterventions:   Drug: methylprednisolone;   Drug: prednisone;   Drug: rituximab [Ristova]Sponsor:   Hoffmann-La RocheSuspended - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2014 Category: Research Source Type: clinical trials

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
Conditions:   Granulomatosis With Polyangiitis (Wegener's);   Granulomatosis With Polyangiitis;   Wegener's Granulomatosis;   ANCA-Associated VasculitisInterventions:   Drug: Abatacept;   Drug: placeboSponsors:   University of South Florida;   The Cleveland Clinic;   Bristol-Myers Squibb;   University of PennsylvaniaNot yet recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2014 Category: Research Source Type: clinical trials

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
Conditions:   Granulomatosis With Polyangiitis (Wegener's);   Granulomatosis With Polyangiitis;   Wegener's Granulomatosis;   ANCA-Associated VasculitisInterventions:   Drug: Abatacept;   Drug: placeboSponsors:   University of South Florida;   The Cleveland Clinic;   Bristol-Myers Squibb;   University of PennsylvaniaRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2014 Category: Research Source Type: clinical trials

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
Conditions:   Granulomatosis With Polyangiitis (Wegener's);   Granulomatosis With Polyangiitis;   Wegener's Granulomatosis;   ANCA-Associated VasculitisInterventions:   Drug: Abatacept;   Drug: placeboSponsors:   University of South Florida;   The Cleveland Clinic;   Bristol-Myers Squibb;   University of PennsylvaniaNot yet recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2014 Category: Research Source Type: clinical trials

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
Conditions:   Granulomatosis With Polyangiitis (Wegener's);   Granulomatosis With Polyangiitis;   Wegener's Granulomatosis;   ANCA-Associated VasculitisInterventions:   Drug: Abatacept;   Drug: placeboSponsors:   University of South Florida;   The Cleveland Clinic;   Bristol-Myers Squibb;   University of PennsylvaniaRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2014 Category: Research Source Type: clinical trials

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions:   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus;   Psoriasis;   Behcet's Disease;   Wegener's Granulomatosis;   Takayasu's Disease;   Crohn's Disease;   Ulcerative Colitis;   Autoimmune Hepatitis;   Sclerosing CholangitisIntervention:   Drug: Interleukin 2Sponsors:   Assistance Publique - Hôpitaux de Paris;   ILTOO PharmaNot yet recruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2013 Category: Research Source Type: clinical trials